Chinese Journal of Dermatology ›› 2021, Vol. 54 ›› Issue (12): 1048-1056.doi: 10.35541/cjd.20210561
• Guidelines and Consensus • Previous Articles Next Articles
Chinese Association of Rehabilitation Dermatology; Photodynamic Therapy Research Center, Chinese Society of Dermatology; Photomedicine Therapeutic Equipment Group, Committee on Skin Disease and Cosmetic Dermatology, China Association of Medical Equipment
Received:
2021-08-04
Revised:
2021-09-25
Online:
2021-12-15
Published:
2021-12-01
Contact:
Wang Xiuli; Gu Heng;Chen Xiang
E-mail:wangxiuli_1400023@tongji.edu.cn;guheng@aliyun.com; chenxiangck@126.com
Chinese Association of Rehabilitation Dermatology, Photodynamic Therapy Research Center, Chinese Society of Dermatology, Photomedicine Therapeutic Equipment Group, Committee on Skin Disease and Cosmetic Dermatology, China Association of Medical Equipment. Expert consensus on clinical diagnosis and treatment of actinic keratosis in China(2021)[J]. Chinese Journal of Dermatology, 2021, 54(12): 1048-1056.doi:10.35541/cjd.20210561
[1] | Ratushny V, Gober MD, Hick R, et al. From keratinocyte to cancer: the pathogenesis and modeling of cutaneous squamous cell carcinoma[J]. J Clin Invest, 2012,122(2):464⁃472. doi: 10.1172/JCI57415. |
[2] | Olsen EA, Abernethy ML, Kulp⁃Shorten C, et al. A double⁃blind, vehicle⁃controlled study evaluating masoprocol cream in the treatment of actinic keratoses on the head and neck[J]. J Am Acad Dermatol, 1991,24(5 Pt 1):738⁃743. doi: 10.1016/0190⁃9622(91)70113⁃g. |
[3] | Lee JH, Kim YH, Han KD, et al. Incidence of actinic keratosis and risk of skin cancer in subjects with actinic keratosis: a population⁃based cohort study[J]. Acta Derm Venereol, 2018,98(3):382⁃383. doi: 10.2340/00015555⁃2854. |
[4] | 涂庆峰, 吕婷, 赖永贤, 等. 上海市某社区老年人皮肤肿瘤流行病学研究[J]. 老年医学与保健, 2013,19(3):142⁃145,148. doi: 10.3969/j.issn.1008⁃8296.2013⁃05. |
[5] | Zhao Y, Li CY, Wen CM, et al. The prevalence of actinic keratosis in patients visiting dermatologists in two hospitals in China[J]. Br J Dermatol, 2016,174(5):1005⁃1010. doi: 10.1111/ bjd.14344. |
[6] | Ferrándiz C, Plazas MJ, Sabaté M, et al. Prevalence of actinic keratosis among dermatology outpatients in Spain[J]. Actas Dermosifiliogr, 2016,107(8):674⁃680. doi: 10.1016/j.ad.2016. 05.016. |
[7] | Fargnoli MC, Altomare G, Benati E, et al. Prevalence and risk factors of actinic keratosis in patients attending Italian dermatology clinics[J]. Eur J Dermatol, 2017,27(6):599⁃608. doi: 10.1684/ejd.2017.3126. |
[8] | Reinehr C, Bakos RM. Actinic keratoses: review of clinical, dermoscopic, and therapeutic aspects[J]. An Bras Dermatol, 2019,94(6):637⁃657. doi: 10.1016/j.abd.2019.10.004. |
[9] | Butani AK, Arbesfeld DM, Schwartz RA. Premalignant and early squamous cell carcinoma[J]. Clin Plast Surg, 2005,32(2):223⁃235. doi: 10.1016/j.cps.2004.11.001. |
[10] | Engel A, Johnson ML, Haynes SG. Health effects of sunlight exposure in the United States. Results from the first National Health and Nutrition Examination Survey, 1971⁃1974[J]. Arch Dermatol, 1988,124(1):72⁃79. |
[11] | de Oliveira E, da Motta V, Pantoja PC, et al. Actinic keratosis ⁃ review for clinical practice[J]. Int J Dermatol, 2019,58(4):400⁃407. doi: 10.1111/ijd.14147. |
[12] | Flohil SC, van der Leest RJ, Dowlatshahi EA, et al. Prevalence of actinic keratosis and its risk factors in the general population: the Rotterdam Study[J]. J Invest Dermatol, 2013,133(8):1971⁃1978. doi: 10.1038/jid.2013.134. |
[13] | Chetty P, Choi F, Mitchell T. Primary care review of actinic keratosis and its therapeutic options: a global perspective[J]. Dermatol Ther (Heidelb), 2015,5(1):19⁃35. doi:10.1007/s13555⁃ 015⁃0070⁃9. |
[14] | Ulrich C, Jürgensen JS, Degen A, et al. Prevention of non⁃melanoma skin cancer in organ transplant patients by regular use of a sunscreen: a 24 months, prospective, case⁃control study[J]. Br J Dermatol, 2009,161 Suppl 3:78⁃84. doi: 10.1111/j.1365⁃2133.2009.09453.x. |
[15] | Criscione VD, Weinstock MA, Naylor MF, et al. Actinic keratoses: natural history and risk of malignant transformation in the Veterans Affairs Topical Tretinoin Chemoprevention Trial[J]. Cancer, 2009,115(11):2523⁃2530. doi: 10.1002/cncr.24284. |
[16] | Dodson JM, DeSpain J, Hewett JE, et al. Malignant potential of actinic keratoses and the controversy over treatment. A patient⁃oriented perspective[J]. Arch Dermatol, 1991,127(7):1029⁃1031. |
[17] | Lopes ML, Silva Júnior FL, Lima KC, et al. Clinicopathological profile and management of 161 cases of actinic cheilitis[J]. An Bras Dermatol, 2015,90(4):505⁃512. doi: 10.1590/abd1806⁃4841.20153848. |
[18] | de Berker D, McGregor JM, Mohd Mustapa MF, et al. British Association of Dermatologists′ guidelines for the care of patients with actinic keratosis 2017[J]. Br J Dermatol, 2017,176(1):20⁃43. doi: 10.1111/bjd.15107. |
[19] | Vatve M, Ortonne JP, Birch⁃Machin MA, et al. Management of field change in actinic keratosis[J]. Br J Dermatol, 2007,157 Suppl 2:21⁃24. doi: 10.1111/j.1365⁃2133.2007.08268.x. |
[20] | Huerta⁃Brogeras M, Olmos O, Borbujo J, et al. Validation of dermoscopy as a real⁃time noninvasive diagnostic imaging technique for actinic keratosis[J]. Arch Dermatol, 2012,148(10):1159⁃1164. doi: 10.1001/archdermatol.2012.1060. |
[21] | Yang X, Hu C, Wen L, et al. Dermoscopic monitoring for treatment and follow⁃up of actinic keratosis with 5⁃aminolaevulinic acid photodynamic therapy[J]. Technology in Cancer Research & Treatment, 2018, 17(3): 153 303381882009. doi:10.1177/1533033818820091. |
[22] | Zalaudek I, Piana S, Moscarella E, et al. Morphologic grading and treatment of facial actinic keratosis[J]. Clin Dermatol, 2014,32(1):80⁃87. doi: 10.1016/j.clindermatol.2013.05.028. |
[23] | 中国医疗保健国际交流促进会皮肤科分会皮肤影像学组, 中华医学会皮肤性病学分会皮肤病数字化诊断亚学组, 中国中西医结合学会皮肤性病专业委员会皮肤影像学组, 等. 鳞状细胞肿瘤皮肤镜特征专家共识(2017)[J]. 中华皮肤科杂志, 2018,51(2):87⁃91. doi: 10.3760/cma.j.issn.0412⁃4030.2018.02. 001. |
[24] | Papageorgiou C, Lallas A, Manoli SM, et al. Evaluation of dermatoscopic criteria for early detection of squamous cell carcinoma arising on an actinic keratosis[J]. J Am Acad Dermatol, 2021:S0190⁃9622(21)00760⁃X. doi: 10.1016/j.jaad.2021.03.111. |
[25] | Jin Q, Li W, Wu W, et al. Assessment of 5⁃aminolaevulinic acid photodynamic therapy (ALA⁃PDT) in Chinese patients with actinic keratosis: correlation of dermoscopic features with histopathology[J]. Australas J Dermatol, 2020,61(3):e339⁃e343. doi: 10.1111/ajd.13289. |
[26] | Prow TW, Tan JM, Pellacani G. Reflectance confocal microscopy: hallmarks of keratinocyte cancer and its precursors[J]. Curr Probl Dermatol, 2015,46:85⁃94. doi: 10.1159/00036 6541. |
[27] | 刘峰, 刘刚, 徐丽敏, 等. 运用共聚焦激光扫描显微镜在术前测定日光性角化病边界的效果分析[J]. 中国皮肤性病学杂志, 2014,28(3):263⁃265+268. |
[28] | Nguyen KP, Peppelman M, Hoogedoorn L, et al. The current role of in vivo reflectance confocal microscopy within the continuum of actinic keratosis and squamous cell carcinoma: a systematic review[J]. Eur J Dermatol, 2016,26(6):549⁃565. doi: 10.1684/ejd.2016.2872. |
[29] | 吴秀娟, 向芳, 赵宗峰, 等. 反射式共聚焦扫描显微镜在日光性角化病诊断中的应用[J]. 中国麻风皮肤病杂志, 2016,32(5):267⁃269. |
[30] | Cockerell CJ. Histopathology of incipient intraepidermal squamous cell carcinoma ("actinic keratosis")[J]. J Am Acad Dermatol, 2000,42(1 Pt 2):11⁃17. doi: 10.1067/mjd.2000.103344. |
[31] | McKee P, Calonje E, Granter S, et al. 皮肤病理学: 与临床的联系[M]. 朱学骏, 孙建方, 译. 3版. 北京: 北京大学医学出版社, 2007:1187⁃1192. |
[32] | Roewert⁃Huber J, Stockfleth E, Kerl H. Pathology and pathobiology of actinic (solar) keratosis ⁃ an update[J]. Br J Dermatol, 2007,157 Suppl 2:18⁃20. doi: 10.1111/j.1365⁃2133. 2007.08267.x. |
[33] | Wong TH, Morton CA, Collier N, et al. British Association of Dermatologists and British Photodermatology Group guidelines for topical photodynamic therapy 2018[J]. Br J Dermatol, 2019,180(4):730⁃739. doi: 10.1111/bjd.17309. |
[34] | Szeimies RM, Radny P, Sebastian M, et al. Photodynamic therapy with BF⁃200 ALA for the treatment of actinic keratosis: results of a prospective, randomized, double⁃blind, placebo⁃controlled phase III study[J]. Br J Dermatol, 2010,163(2):386⁃394. doi: 10.1111/j.1365⁃2133.2010.09873.x. |
[35] | 中华医学会皮肤性病学分会光动力治疗研究中心, 中国康复医学会皮肤病康复专业委员会, 中国医学装备协会皮肤病与皮肤美容分会光医学治疗装备学组. 氨基酮戊酸光动力疗法皮肤科临床应用指南(2021版)[J]. 中华皮肤科杂志, 2021,54(1):1⁃9. doi: 10.35541/cjd.20200731. |
[36] | Zhu L, Wang P, Zhang G, et al. Conventional versus daylight photodynamic therapy for actinic keratosis: a randomized and prospective study in China[J]. Photodiagnosis Photodyn Ther, 2018,24:366⁃371. doi: 10.1016/j.pdpdt.2018.10.010. |
[37] | Cai H, Wang YX, Sun P, et al. Photodynamic therapy for facial actinic keratosis: a clinical and histological study in Chinese patients[J]. Photodiagnosis Photodyn Ther, 2013,10(3):260⁃265. doi: 10.1016/j.pdpdt.2012.12.003. |
[38] | Tschen EH, Wong DS, Pariser DM, et al. Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12⁃month follow up[J]. Br J Dermatol, 2006,155(6):1262⁃1269. doi: 10.1111/j.1365⁃2133.2006.07520.x. |
[39] | Jansen M, Kessels J, Nelemans PJ, et al. Randomized trial of four treatment approaches for actinic keratosis[J]. N Engl J Med, 2019,380(10):935⁃946. doi: 10.1056/NEJMoa1811850. |
[40] | Zhang L, Zhao Z, Wang P, et al. Long⁃term improvement on photoaging after ALA photodynamic therapy for actinic keratosis: a retrospective study[J]. Photodiagnosis Photodyn Ther, 2021,33:102181. doi: 10.1016/j.pdpdt.2021.102181. |
[41] | Chen J, Zhang Y, Wang P, et al. Plum⁃blossom needling promoted PpIX fluorescence intensity from 5⁃aminolevulinic acid in porcine skin model and patients with actnic keratosis[J]. Photodiagnosis Photodyn Ther, 2016,15:182⁃190. doi: 10.1016/j.pdpdt.2016.06.012. |
[42] | Zheng Z, Zhang LL, Shi L, et al. What is the most relevent factor causing pain during ALA⁃PDT? A multi⁃center, open clinical pain score research trial of actinic keratosis, acne and condylomata acuminata[J]. Photodiagnosis Photodyn Ther, 2019,26:73⁃78. doi: 10.1016/j.pdpdt.2019.03.001. |
[43] | Ibbotson SH, Wong TH, Morton CA, et al. Adverse effects of topical photodynamic therapy: a consensus review and approach to management[J]. Br J Dermatol, 2019,180(4):715⁃729. doi: 10.1111/bjd.17131. |
[44] | Dréno B, Amici JM, Basset⁃Seguin N, et al. Management of actinic keratosis: a practical report and treatment algorithm from AKTeam™ expert clinicians[J]. J Eur Acad Dermatol Venereol, 2014,28(9):1141⁃1149. doi: 10.1111/jdv.12434. |
[45] | Stockfleth E, Meyer T, Benninghoff B, et al. A randomized, double⁃blind, vehicle⁃controlled study to assess 5% imiquimod cream for the treatment of multiple actinic keratoses[J]. Arch Dermatol, 2002,138(11):1498⁃1502. doi: 10.1001/archderm.138. 11.1498. |
[46] | Szeimies RM, Gerritsen MJ, Gupta G, et al. Imiquimod 5% cream for the treatment of actinic keratosis: results from a phase III, randomized, double⁃blind, vehicle⁃controlled, clinical trial with histology[J]. J Am Acad Dermatol, 2004,51(4):547⁃555. doi: 10.1016/j.jaad.2004.02.022. |
[47] | Swanson N, Smith CC, Kaur M, et al. Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: two phase 3 multicenter, randomized, double⁃blind, placebo⁃controlled studies[J]. J Drugs Dermatol, 2013,12(11):1278⁃1282. |
[48] | 王宏伟, 王秀丽, 过明霞. 外用咪喹莫特乳膏致局限型白癜风二例[J]. 中华皮肤科杂志, 2006,39(10):613. doi: 10.3760/j.issn:0412⁃4030.2006.10.029. |
[49] | Segatto MM, Dornelles SI, Silveira VB, et al. Comparative study of actinic keratosis treatment with 3% diclofenac sodium and 5% 5⁃fluorouracil[J]. An Bras Dermatol, 2013,88(5):732⁃738. doi: 10.1590/abd1806⁃4841.20132083. |
[50] | Dianzani C, Conforti C, Giuffrida R, et al. Current therapies for actinic keratosis[J]. Int J Dermatol, 2020,59(6):677⁃684. doi: 10.1111/ijd.14767. |
[51] | Werner RN, Jacobs A, Rosumeck S, et al. Methods and results report ⁃ evidence and consensus⁃based (S3) guidelines for the treatment of actinic keratosis ⁃International League of Dermatological Societies in cooperation with the European Dermatology Forum[J]. J Eur Acad Dermatol Venereol, 2015,29(11):e1⁃e66. doi: 10.1111/jdv.13179. |
[52] | Walker JL, Siegel JA, Sachar M, et al. 5⁃Fluorouracil for actinic keratosis treatment and chemoprevention: a randomized controlled trial[J]. J Invest Dermatol, 2017,137(6):1367⁃1370. doi: 10.1016/j.jid.2016.12.029. |
[53] | Stough D, Bucko AD, Vamvakias G, et al. Fluorouracil cream 0.5% for actinic keratoses on multiple body sites: an 18⁃month open⁃label study[J]. Cutis, 2010,85(5):267⁃273. |
[54] | Hoover WD 3rd, Jorizzo JL, Clark AR, et al. Efficacy of cryosurgery and 5⁃fluorouracil cream 0.5% combination therapy for the treatment of actinic keratosis[J]. Cutis, 2014,94(5):255⁃259. |
[55] | Stockfleth E, von Kiedrowski R, Dominicus R, et al. Efficacy and safety of 5⁃fluorouracil 0.5%/salicylic acid 10% in the field⁃directed treatment of actinic keratosis: a phase iii, randomized, double⁃blind, vehicle⁃controlled trial[J]. Dermatol Ther (Heidelb), 2017,7(1):81⁃96. doi: 10.1007/s13555⁃016⁃0161⁃2. |
[56] | Ulrich M, Reinhold U, Falqués M, et al. Use of reflectance confocal microscopy to evaluate 5⁃fluorouracil 0.5%/salicylic acid 10% in the field⁃directed treatment of subclinical lesions of actinic keratosis: subanalysis of a Phase III, randomized, double⁃blind, vehicle⁃controlled trial[J]. J Eur Acad Dermatol Venereol, 2018,32(3):390⁃396. doi: 10.1111/jdv.14611. |
[57] | Rivers JK, Arlette J, Shear N, et al. Topical treatment of actinic keratoses with 3.0% diclofenac in 2.5% hyaluronan gel[J]. Br J Dermatol, 2002,146(1):94⁃100. doi: 10.1046/j.1365⁃2133.2002. 04561.x. |
[58] | Akarsu S, Aktan S, Atahan A, et al. Comparison of topical 3% diclofenac sodium gel and 5% imiquimod cream for the treatment of actinic keratoses[J]. Clin Exp Dermatol, 2011,36(5):479⁃484. doi: 10.1111/j.1365⁃2230.2010.03999.x. |
[59] | Kang S, Goldfarb MT, Weiss JS, et al. Assessment of adapalene gel for the treatment of actinic keratoses and lentigines: a randomized trial[J]. J Am Acad Dermatol, 2003,49(1):83⁃90. doi: 10.1067/mjd.2003.451. |
[60] | Ianhez M, Pinto SA, Miot HA, et al. A randomized, open, controlled trial of tretinoin 0.05% cream vs. low⁃dose oral isotretinoin for the treatment of field cancerization[J]. Int J Dermatol, 2019,58(3):365⁃373. doi: 10.1111/ijd.14363. |
[61] | Thai KE, Fergin P, Freeman M, et al. A prospective study of the use of cryosurgery for the treatment of actinic keratoses[J]. Int J Dermatol, 2004,43(9):687⁃692. doi: 10.1111/j.1365⁃4632.2004. 02056.x. |
[62] | Zane C, Facchinetti E, Rossi MT, et al. Cryotherapy is preferable to ablative CO2 laser for the treatment of isolated actinic keratoses of the face and scalp: a randomized clinical trial[J]. Br J Dermatol, 2014,170(5):1114⁃1121. doi: 10.1111/bjd. 12847. |
[63] | Ianhez M, Fleury LF Jr, Miot HA, et al. Retinoids for prevention and treatment of actinic keratosis[J]. An Bras Dermatol, 2013,88(4):585⁃593. doi: 10.1590/abd1806⁃4841.20131803. |
[64] | de Sévaux RG, Smit JV, de Jong EM, et al. Acitretin treatment of premalignant and malignant skin disorders in renal transplant recipients: clinical effects of a randomized trial comparing two doses of acitretin[J]. J Am Acad Dermatol, 2003,49(3):407⁃412. doi: 10.1067/s0190⁃9622(03)01831⁃0. |
[65] | 中国医师协会皮肤科医师分会皮肤美容事业发展工作委员会. 皮肤防晒专家共识(2017)[J]. 中华皮肤科杂志, 2017,50(5):316⁃320. doi:10.3760/cma.j.issn.0412⁃4030.2017.05.002. |
[1] | Lyu Ling, Lyu Xiaoyan. Dermatomyositis with malignancy: an update [J]. Chinese Journal of Dermatology, 2022, 55(3): 276-279. |
[2] | Li Suo, Xiang Ruiyu, Li Zhiliang, Jing Ke, Wang Yuan, Zhang Hanmei, Feng Suying. Evaluation of the value of indirect immunofluorescence on salt-split skin in the diagnosis of bullous pemphigoid [J]. Chinese Journal of Dermatology, 2022, 55(3): 235-237. |
[3] | Writing committee expert group on “diagnosis and treatment of pustular psoriasis: a Chinese expert consensus statement”. Diagnosis and treatment of pustular psoriasis: a Chinese expert consensus statement (2022) [J]. Chinese Journal of Dermatology, 2022, 55(3): 187-195. |
[4] | Wang Yuan, Yu Meiwen, Xiang Ruiyu, Li Suo, Li Zhiliang, Jin Ke, Zhang Hanmei, Feng Suying. Optimization of indirect immunofluorescence on salt-split skin and its application in detection of bullous pemphigoid antibodies [J]. Chinese Journal of Dermatology, 2022, 55(1): 12-15. |
[5] | Zhang Ying, Gan Lu, Li Siqi, Li Yan, Song Hao, Shao Xuebao, Zhang Wei, Xu Xiulian, Jiang Yiqun, Zeng Xuesi, Chen Hao, Sun Jianfang. Clinicopathological and immunophenotypic analysis of 24 cases of transformed mycosis fungoides [J]. Chinese Journal of Dermatology, 2022, 55(1): 20-26. |
[6] | Chinese Society of Dermatology, China Dermatologist Association. Consensus on the diagnosis and treatment of autoimmune subepidermal bullous diseases (2022) [J]. Chinese Journal of Dermatology, 2022, 55(1): 1-11. |
[7] | Cheng Bihong, Dou Xia. Diagnosis and classification of chronic prurigo [J]. Chinese Journal of Dermatology, 2022, 0(1): 20210130-e20210130. |
[8] | Wang Yifei, Geng Yi, Miao Qiuju, Song Hao, Xu Xiulian, Sun Jianfang. Clinicopathological analysis of ten cases of mucinous nevi [J]. Chinese Journal of Dermatology, 2021, 54(9): 804-807. |
[9] | Qiu Yueqi, Fu Siqi, Luo Shuaihantian, Li Yaping, Zhang Guiying. Research advance in androgenetic alopecia in 2020 [J]. Chinese Journal of Dermatology, 2021, 54(9): 835-838. |
[10] | Autoimmune Disease Group, China Dermatologist Association. Chinese expert consensus on cyclophosphamide for the treatment of autoimmune dermatoses [J]. Chinese Journal of Dermatology, 2021, 54(9): 765-770. |
[11] | Zhang Xiao, Fu Meng, Wang Lei, Liu Yu, Gao Tianwen, Liu Ling. Analysis of 118 cases of clinically misdiagnosed cutaneous melanoma [J]. Chinese Journal of Dermatology, 2021, 54(9): 771-776. |
[12] | Skin Tumor Research Center, Chinese Society of Dermatology, Subcommittee on Skin Tumor, China Dermatologist Association. Expert consensus on diagnosis and treatment of cutaneous basal cell carcinoma (2021) [J]. Chinese Journal of Dermatology, 2021, 54(9): 757-764. |
[13] | Song Ge, Liang Guanzhao, Zhang Meijie, Dong Jiacheng, Liu Weida. Clinical diagnosis and treatment of tinea of vellus hair [J]. Chinese Journal of Dermatology, 2021, 54(8): 741-743. |
[14] | Wang Daguang, Jiang Jiayi. Considerations in the diagnosis and treatment of several nail diseases [J]. Chinese Journal of Dermatology, 2021, 54(8): 733-737. |
[15] | Song Zhiqiang, Gu Heng. Enhancing standardization of diagnostic terminology for dermatitis and eczematous disorders [J]. Chinese Journal of Dermatology, 2021, 54(8): 665-667. |
|